HIRSCHMAN ORIN 13D and 13G filings for MEDICENNA THERAPEUTICS CORP:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-07 6:55 pm Purchase |
2023-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF |
HIRSCHMAN ORIN | 4,672,075 6.700% |
242,092![]() (+5.46%) |
Filing |
2023-02-15 06:35 am Purchase |
2022-12-31 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF |
HIRSCHMAN ORIN | 4,429,983 6.400% |
516,829![]() (+13.21%) |
Filing |
2022-10-20 06:02 am Purchase |
2022-08-10 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF |
HIRSCHMAN ORIN | 3,913,154 5.600% |
3,913,154![]() (New Position) |
Filing |